
AgeX Therapeutics, Inc.
AMEX:AGE
Overview | Financials
Company Name | AgeX Therapeutics, Inc. |
Symbol | AGE |
Currency | USD |
Price | 0.43 |
Market Cap | 16,326,649 |
Dividend Yield | 0% |
52-week-range | 0.361 - 1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Joanne M. Hackett Ph.D. |
Website | https://www.agexinc.com |
An error occurred while fetching data.
About AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD